VRAX heads into the week after a striking reset in its lending market — cost to borrow has fallen from extreme triple-digit levels to a fraction of where it was six weeks ago, even as the stock itself keeps climbing.
The borrow story is the defining feature of this setup. Cost to borrow peaked above 300% in early April, briefly hitting 309% on April 1. By this week it had retreated to roughly 34% — a dramatic easing that reflects a material reduction in short demand. Short interest, measured against the current free float via ORTEX daily estimates, has pulled back to around 3.5% of float, down sharply from peaks north of 10% in mid-April. That is a significant deceleration: the month-on-month change in shares short is down more than 52%. Borrow availability has loosened considerably in tandem. Utilisation — how much of the available lending pool is actually in use — had hit 94% in mid-April. It now reads just 10%, meaning roughly nine out of every ten available shares are no longer lent out. The pool is far from full.
Yet the price has moved the other way. VRAX gained nearly 27% on Friday alone and is up 30% on the week, trading at $0.171. A stock this small — no market cap is currently available, but the share price and float size suggest micro-cap territory — can move sharply on thin volume. The combination of retreating short interest and rising price is consistent with a short unwind driving at least part of the rally. The ORTEX short score has climbed back to 46.6 this week after falling as low as 33 on May 5, reflecting a pickup in short-side pressure even as aggregate short exposure has declined — a sign that some new positioning is building even as prior shorts exit.
Analyst coverage is thin and the most recent data is stale. HC Wainwright lowered its price target to $1.00 from $3.00 in January — a significant cut — while maintaining a Buy rating. With the stock trading at $0.17, the $1.00 target implies substantial theoretical upside, but that data is now four months old and should be treated with caution given how active the stock has been. No other analyst activity is on record. Factor scores offer limited additional colour: the days-to-cover rank is at the 98th percentile, flagging the stock as having an exceptionally high DTC reading relative to the universe, while the short score rank of 29 reflects relatively modest short-side conviction by ORTEX's composite measure.
Earnings history adds another layer of context. The last four prints produced wildly divergent outcomes: a 76% single-day gain on December 2, a flat reaction in March, and moves ranging from -4% to +70% over five-day windows. The next event is scheduled for June 12. With a stock that has shown it can move in either direction by double digits around results — and a borrow market that has just passed through one of its most extreme stress episodes in recent memory — the June print will be watched closely by anyone still carrying a position.
Peer names NAKA and DCGO both fell roughly 10-15% on the week while VRAX surged, underscoring how idiosyncratic this move has been. What to watch: whether the short score continues its recent rebound toward 50, and whether the cost to borrow stabilises or resumes its decline as new short demand either materialises or fails to appear ahead of June earnings.
See the live data behind this article on ORTEX.
Open VRAX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
